V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208698 | 20174447 | 1.7 | 83 | null | 2020-04-18 | 2020-04-27 | CISPLATIN + GEMCITABINE | 02 | null | CAPECITABINE + IRINOTECAN | 100090977 |
| 20208733 | 20174448 | 1.58 | 86.9 | Palliative (P) | 2022-01-07 | 2022-01-07 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 100427974 |
| 20208740 | 20174449 | 1.81 | 71.55 | Neo-adjuvant (N) | 2017-09-29 | 2017-11-11 | Capecitabine (21 day) + Irinotecan | N | N | CAPECITABINE + IRINOTECAN | 100032381 |
| 20208749 | 20174450 | 1.76 | 54.3 | Neo-adjuvant (N) | null | 2018-03-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101495759 |
| 20208755 | 20174451 | 1.82 | 76.4 | Palliative (P) | 2019-07-25 | 2020-01-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100137462 |
| 20208784 | 20174452 | 1.76 | 49.9 | Palliative (P) | null | 2021-05-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100323656 |
| 20208837 | 20174453 | 1.81 | 65.3 | Adjuvant (A) | null | 2021-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101679011 |
| 20208840 | 20174454 | 1.87 | 129.1 | null | 2017-11-24 | 2017-11-30 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100986161 |
| 20208841 | 20174455 | 1.8 | 78 | Palliative (P) | 2020-07-23 | 2020-07-31 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100557397 |
| 20208875 | 20174456 | 1.53 | 56.2 | Palliative (P) | 2021-11-06 | 2021-11-10 | Docetaxel | 02 | N | DOCETAXEL | 101044507 |
| 20208887 | 20174457 | 1.59 | 57 | Palliative (P) | 2020-08-26 | 2020-09-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101484727 |
| 20208891 | 20174458 | 1.67 | 60.6 | Palliative (P) | 2021-07-16 | 2021-07-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100614783 |
| 20208993 | 20174459 | 1.76 | 78.1 | null | null | 2019-09-01 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100262930 |
| 20209036 | 20174460 | 1.74 | 65 | null | 2016-05-16 | 2016-10-24 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100919069 |
| 20209051 | 20174461 | 1.67 | 87.9 | Palliative (P) | 2018-03-15 | 2018-04-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100045030 |
| 20209054 | 20174462 | 1.54 | 64.7 | Neo-adjuvant (N) | 2021-06-06 | 2021-07-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100625375 |
| 20209108 | 20174464 | 1.67 | 67.95 | null | 2020-10-15 | 2020-10-15 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100796755 |
| 20209136 | 20174465 | 1.7 | 92.7 | Palliative (P) | 2018-09-04 | 2018-09-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101455600 |
| 20209149 | 20174466 | 1.74 | 56 | Palliative (P) | 2020-01-21 | 2020-05-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101216174 |
| 20209151 | 20174467 | 1.63 | 61.9 | Palliative (P) | 2021-11-17 | 2021-11-23 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 100691712 |
| 20209204 | 20174469 | 0 | 63.05 | Palliative (P) | 2017-12-05 | 2017-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101225679 |
| 20209213 | 20174470 | 1.88 | 64.5 | Palliative (P) | 2020-01-13 | 2020-01-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101411465 |
| 20209218 | 20174471 | 1.63 | 69.2 | null | 2022-05-14 | 2022-05-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101611987 |
| 20209237 | 20174472 | 1.79 | 48.25 | null | 2021-03-21 | 2021-04-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101172451 |
| 20209249 | 20174473 | 1.63 | 90.4 | Palliative (P) | 2021-10-21 | 2021-12-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100644292 |
| 20209349 | 20174474 | 1.93 | 81.3 | Neo-adjuvant (N) | 2020-04-22 | 2020-06-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101420227 |
| 20209473 | 20174475 | 1.74 | 59.6 | null | 2022-03-10 | 2022-03-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100036114 |
| 20209491 | 20174476 | 1.85 | 74 | Palliative (P) | 2016-04-14 | 2016-04-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100823261 |
| 20209549 | 20174477 | 1.59 | 138.8 | 03 | 2021-08-12 | 2021-08-26 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101688674 |
| 20209558 | 20174478 | 1.63 | 84.2 | Adjuvant (A) | 2020-05-13 | 2020-05-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100910086 |
| 20209704 | 20174479 | 1.71 | 79.1 | null | 2020-02-16 | 2020-03-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101729886 |
| 20209705 | 20174480 | 1.7 | 77.45 | null | 2020-04-28 | 2020-05-11 | Docetaxel | N | null | DOCETAXEL | 101417591 |
| 20209738 | 20174481 | 1.67 | 77.3 | null | 2017-10-04 | 2018-04-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100520149 |
| 20209775 | 20174482 | 1.54 | 72 | Palliative (P) | 2018-07-08 | 2018-11-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101634766 |
| 20209794 | 20174483 | 1.61 | 67.1 | null | 2017-09-18 | 2017-09-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101380848 |
| 20209798 | 20174484 | 1.55 | 83.3 | null | 2021-11-27 | 2021-12-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101849799 |
| 20209840 | 20174485 | 1.54 | 114.8 | null | 2017-10-06 | 2017-10-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100975261 |
| 20209843 | 20174486 | 1.59 | 58 | null | 2017-04-27 | 2017-06-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101139270 |
| 20209902 | 20174487 | 1.74 | 62.25 | Palliative (P) | 2020-07-09 | 2020-07-25 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100492349 |
| 20209907 | 20174488 | 1.76 | 79.8 | Palliative (P) | 2020-05-21 | 2020-05-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101787960 |
| 20209917 | 20174489 | 1.54 | 117.9 | Palliative (P) | 2020-06-27 | 2020-06-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100547280 |
| 20209928 | 20174490 | 1.88 | 80 | null | 2017-12-06 | 2017-12-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100982535 |
| 20209950 | 20174491 | 1.7 | 79 | null | 2019-12-30 | 2020-01-23 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101468199 |
| 20209983 | 20174492 | 1.67 | 53.5 | Adjuvant (A) | 2020-04-03 | 2020-04-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100007128 |
| 20210021 | 20174493 | 1.51 | 57.4 | Palliative (P) | 2021-09-30 | 2021-12-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100964593 |
| 20210024 | 20174494 | 1.76 | 55.5 | Palliative (P) | 2020-02-03 | 2020-05-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101677655 |
| 20210029 | 20174495 | 1.7 | 71 | Palliative (P) | 2019-08-11 | 2019-08-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101636630 |
| 20210113 | 20174496 | 1.68 | 55 | Palliative (P) | 2019-02-24 | 2019-07-04 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101820538 |
| 20210114 | 20174497 | 1.5 | 78 | Palliative (P) | 2020-04-11 | 2020-05-20 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101173437 |
| 20210268 | 20174499 | 1.6 | 61 | Adjuvant (A) | 2021-09-07 | 2021-09-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100547071 |